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Summary
Class I major histocompatibility complex (MHC) restrictedT lymphocytes preferentially recognize
fragments of polypeptides processed through a nonendosomal presentation pathway . At present
the intracellular compartment(s) in which polypeptide fragmentation occurs and factors which
influence the formation of an antigenic epitope are not well understood . To assess the role of
residues flanking an antigenic site in the generation of the antigenic moiety recognized by class
IMHC restricted T lymphocytes we have moved the coding sequence for an immunodominant
H-2Kd restricted site on the influenza A/JAPAN/57 hemagglutinin (residues 202-221) by site-
directed mutagenesis to six different positions along the coding sequence of the hemagglutinin
gene. We have found that all six classes of mutants are recognized by MHC class I restricted
T cells as efficiently as the wild type hemagglutinin gene product . Thus neither N-terminal
to C-terminal position within the translation product nor sequences flanking the antigenic site
influence processing .
Major histocompatibility complex class I restricted T lym-
phocytes appear to play a central role in the recovery
from viral infection (1) . Unlike the antigen-specific receptor
on B lymphocytes which recognizes free antigens, the an-
tigen receptor on theseT lymphocytes recognize non-native
fragments of large polypeptides complexed to MHC mole-
cules (2) . Fragments of both nonglycosylated cytosolic pro-
teins (3) and membrane glycoproteins (4) can be recognized
byMHC class I restrictedT cells in virally infected cells. These
processed viral antigens appear to preferentially associate with
nascent class IMHC molecules in a pre-Golgi compartment
before export of the peptide MHC complex to the cell sur-
face (5) .
At present very little information is available on the na-
ture of the fragmentation process yielding the antigenic epi-
topes, the specific protease(s) involved or the mechanism of
transport of antigen fragments between compartments within
a cell . In particular, it is notknown iffactors such as location
of a site within a protein or flanking residues affect the pro-
cessing and presentation of a site and therefore the immunoge-
nicity of a site. In this reportwe have examined the influence
of flanking sequences bordering an immunodominant anti-
genic site in theA/JAPAN/57 influenza hemagglutinin (HA)
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on the processing of the antigenic epitope recognized by H-
2Kd restricted CTL after de novo HA expression in target
cells . Our strategy, to re-insert in frame the coding sequence
for the immunodominant HA 202-221 site at different loca-
tions within the HA gene yielded mutant HAs which are
recognized by HA 202-221 specific CTL as efficiently as the
wild typeHA translation product . The implications of these
observations are that highly specific processing information
is inherent in the HA 202-221 site and not in neighboring
amino acid residues, or that some aspects of processing are
fairly nonspecific.
Materials and Methods
Generation ofHA Mutant Constructs.
￿
To construct plasmids con-
taining the repositioned HA 202-221 epitope, the epitope site was
first deleted from the A/JAPAN/57 HA cDNA by site-directed,
loopout mutagenesis in M13 bacteriophage using a double-primer
for the annealing step and extensionof the primer with theklenow
fragment of Escherichia coli polymerase (6) . The sequence of the
HA 202-221 deletion mutant and the corresponding oligonucleo-
tide are shown in Fig . 1 a . The mutantHA gene was inserted into
the shuttle vector pMT21, to facilitate subsequent insertion ofthe
coding sequence forHA 202-221 at specific restriction endonuclear
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digestedat selected restriction sites within theHA coding sequence.
Synthetic oligonucleotides encoding the HA 202-221 epitope and
several flanking bases were inserted in frame into the existing HA
open reading frame to produce the antigenic site. A Hind III-SspI
fragment containing the HA gene with the prepositioned site was
excised from the plasmid and inserted into the vaccinia expression
vector under the control ofa vaccinia virus promoter (7.5 kD) using
thevaccinia psc11.3 insertion vector. The vaccinia virus recombinants
encoding the altered HA mutants were generated by insertion at
the vaccinia virus thymidine kinase locus using standard techniques.
T Cell Clones, Cell Lines.
￿
The clonedT lymphocytes were de-
rived from BALB/c or BALB/cxC57BL/6(CB6) mice. Clones have
been established and maintained as previously described (7) . The
clones were passaged weekly in the presence of A/JAPAN/57-
infected irradiated syngeneic murine splenocytes and exogenous
source T cell growth factors of rat splenocyte origin. The P815
(H-2d) mastocytoma cell line was maintained in DME sup-
plemented with 10% (vol/vol) fetal bovine serum and 1% (wt/vol)
glutamine.
Assayfor Cell-mediated Cytotoxicity .
￿
P815 was used as targets
in standard "Cr-release assays as described (7) . Target cells were
infected with 20MOI vaccinia recombinants and labeled with 100
P.Ci "CL Labeled target cells were washed twice with media and
incubated with effector cells at 37°C for 6 h . Values for percent
specific release represent the mean counts per min ofquadruplicate
cultures.
Results and Discussion
The A/JAPAN/57 HA contains two immunodominant
sites recognized by CD8+ T lymphocytes in association
with the H-2Kd molecule. These sites span residues 202-221
in the HAI portion of theHA and residues 523-545 within
the transmembrane domain of theHA (8). TheN terminal
202-221 site consists of two overlapping subsites, HA 202-
212 and HA 211-221 which are recognized by Kd restricted
CTL clones 11-1 and 40-2 respectively (9) .
To examine the influence of amino acids neighboring an
antigenic epitope on the processing and presentation of the
site toMHC class I restrictedT lymphocytes we constructed
a panel of HA mutants in which the HA 202-221 site was
repositioned within the coding sequence of the HA . Our
strategy was first to delete the coding sequence for residues
202-221 by loopout mutagenesis and then to reinsert the
coding sequence for the 202-221 site at different locations
within the HA gene . Using this approach we have inserted
HA 202-221 in frame at amino acid positions 2, (in the signal
sequence), 33 and 101 in the HA1 and at HA2 positions 430,
466 and at the end of the cytoplasmic tail of the HA (i.e.,
residue 563, Fig. 1 b) . These mutant HA genes designated
HAMI through HAM6 were sequenced in the region sur-
rounding the repositioned 202-221 site and the derived amino
acid sequence of these flanking sequences is as shown (Fig .
1 c) . Mutant HAM2 has undergone a frame shift mutation
within the repositioned 202-221 site resulting in a loss of
residues 215 through 221 of the immunodominant site and
the formation ofa stop codon in the new reading frame four
residues downstream of the insert (Fig . 1 c) .
The mutant HA genes containing the repositioned 202-
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￿
Epitope Localization and Cytotoxic T Lymphocyte Recognition
Figure 1.
￿
Localization and sequence of the repositioned HA 202-221
site. The coding sequencefor theHA202-221 site was deletedfrom influenza
HA gene cDNA by loopout mutagenesis . The oligonucleotide used to
generate the inframe mutant is underlined and included along with the
derived amino acid sequence of the resulting deletionmutant (a). TheHA
202-221 coding sequence was repositioned in the HA coding sequence
at the indicated sites (b) . The sequence of the HA translation product
franking the repositioned epitope is as shown (c) . TheHAM2 mutant which
has a frame shift mutation within the coding sequence for the repositioned
HA 202-221 site is shown as indicated by an asterisk ( " ) .
221 sites were expressed in H-2d haplotype P815 target cells
using recombinant vaccinia virus expression vectors and CTL
recognition was determined using two Kd restricted clones
11-1 and 40-2 which recognize two overlapping sites . Func-
tional recognition of these mutant HA expressing cells by
HA 523-545 specific clones 14-7 and C-1 (10) provided an
assessment ofthe processing and presentation of an indepen-
dent site .
As Fig. 2 a shows, repositioning of the immunodominant
202-221 site had no effect on the presentation of the epitope
to the clone 11-1 . This clone recognized the HA mutants
with similar efficiency . As expected, this CTL clone did not
recognize the HAM7 deletion mutant which lacks the 202-
221 site . Clone 40-2 which is directed to the C-terminal 211-
221 subsite (9) recognizes five of the six repositioned mu-
tants to the same extent as the wild type HA . It does not,
however, recognize target cells expressing the HAM2 mu-
tant which lacks the coding sequence for HA residues 215
through 221 .
Repositioning ofthe 202-221 site along the coding sequenceFigure 2 .
￿
Class I MHC restricted recognition of the repositioned HA
202-221 site. The P815 (H-2d) mastocytoma cell line was infected with
vaccinia recombinants encoding the 0-galactosidase gene (VVSC11), the
A/JAPAN/57 HA (VVHA) or altered HA mutants (VVHAMI, 2, 3,
4, 5, 6, and 7) at a multiplicity of infection of 20 and used as targets in
a standard 6-h s1Cr release assay. Effector to target ratio was 5 :1 . Values
are the means of quadruplicate assay . (a) CTL clones 11-1 and 40-2 which
recognize the N- and C-terminal portions of the HA 202-221 site were
used in the cytotoxicity assay. (b) Clones 14-7 and C1 which are directed
to the HA 523-545 anchor site were used in the assay.
of the HA gene had no effect on the processing and presenta-
tion of the C-terminal 523-545 site for recognition by site-
specific T cell clones (14-7 and C1) which lysed target cells
expressing wild type HA and the HA mutants with com-
parable efficiency. It is noteworthy that the HAM2 mutant
which is in a different reading frame after the insertion of
HA 202-221 at position 33 is also recognized by the C-terminal
523-545 reactive clones when expressed in H-2d haplotype
P815 cells.
These studies demonstrate that neither the position of the
epitope or the flanking sequence affected the presentation of
the newly synthesized antigenic moiety toMHC class I re-
stricted T lymphocytes. The cytoplasm has been implicated
as a major site of processing of antigens for subsequent
charging ofclass IMHC molecules and recognition byMHC
class I restricted T lymphocytes for cytoplasmic proteins (3),
protein antigens which are microinjected into the cell
cytoplasm (11), and for cells expressing minigenes whose pep-
tide products are expressed in the cell cytoplasm (12) . Indeed,
a putative transporter gene has been recently identified (13) .
In the case ofglycoprotein antigens, early evidence suggested
that glycoproteins were presented to class I restricted T cells
through a nonendosomal presentation pathway (14) . Both
the cytoplasm and the endoplasmic reticulum could serve as
potential sites ofnonendosomal proteolysis ofglycoproteins .
Evidence in support of the cytoplasm as the site of glycopro-
tein fragmentation first came from the observation that class
IMHC restrictedT cells could recognize target cells expressing
the signal minus form of the hemagglutinin (15) . This is fur-
ther supported by observations reported here that there is
efficient recognition of the HAM6 mutants by CTL since
it has a signal sequence and the repositioned HA 202-221
site is located in the cytoplasmic tail region of the HA mole-
cule translocation of the mutant HA into the endoplasmic
reticulum (Fig. 1 b) .
We cannot formally exclude the possibility thatHA frag-
ments generated in the endoplasmic reticulum can provide
a source of peptide fragments for class IMHC charging . In-
deed-there is evidence that nascent class IMHC molecules
resident in an endoplasmic reticulum compartment may be
capable ofdirectly binding free peptide fragments (5) . As noted
above, it is not easy to explain the recognition of theHAM6
mutant or existence of sites which map to the transmem-
brane domain (4) or the signal sequence of glycoproteins by
a mechanism involving fragmentation of theHA translation
product in the endoplasmic reticulum . It may be that both
the cytoplasm and the endoplasmic reticulum can provide pep-
tide fragments for MHC class I charging.
In conclusion, our findings suggest that the processing and
presentation machinery involved in fragmentation ofantigens
for presentation to MHC class I restricted T cells are not
influenced by residues outside the antigenic site recognized
by theMHC class I restricted T cells. This is in contrast to
observations on the processing and presentation of antigen
toMHC class II restricted T cells where residues outside of
the antigenic site appear to alter processing and presentation
(16) . Although exceptions have been reported (17), it appears
that the proteases carrying out processing in the class I pre-
sentation pathway act nonspecifically. This particular over-
lapping double site therefore permits further studies as to
the presence of specific versus random cleavage sites within
the HA 202-221 region .
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